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Renal Cell Carcinoma in an End-stage
Kidney: Evaluation with Spectral Doppler
Ultrasound
Ho Yun Lee, Seung Hyup Kim, Sung Il Jung, Sung Il Hwang,
Sun Ho Kim and Hak Jong Lee
The major reason for clinical concern in end-stage renal disease (ESRD) is the
increased incidence of renal cell carcinoma (RCC). Ultrasound (US) has been the
imaging procedure of choice in patients with impaired renal function. However, the
small kidneys of ESRD are often difficult to image with US. We present spectral
Doppler US findings in a case of RCC associated with ESRD and suggest the use
of spectral Doppler US in the detection and differential diagnosis of RCC associated
with ESRD. In our case, the Doppler US spectrum in the RCC showed high peak
systolic velocity and low resistance, which was quite different from the high-
resistance spectrum in other parts of the kidney. High peak systolic velocity in renal
malignancies is probably due to intratumoral arteriovenous shunting. Abnormal blood
vessels formed by an angiogenic factor secreted in malignant lesions lack the normal
requisite of smooth muscle cells within their walls. Consequently, resistance to flow
is decreased and diastolic flow is increased, resulting in a low-resistance flow pattern.
Hence, spectral Doppler US can be used in the evaluation of kidneys with ESRD,
especially when RCC is suspected.
(J Med Ultrasound 2004;12:91–4)
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INTRODUCTION
The prevalence of renal cell carcinoma (RCC) is
higher in patients with end-stage renal disease
(ESRD) than in the general population [1]. Patients
who have undergone long-term hemodialysis and
peritoneal dialysis often develop atrophic kidneys
and subsequent acquired cystic kidney diseases
(ACKD), both of which are associated with RCC
[1–6]. Patients with ACKD are known to develop
RCC much more often than those with otherwise
healthy kidneys [2]. ACKD is accompanied by
intracystic clot formation and fibrous tissue, both of
which mimic malignant disease on computed tomo-
graphy (CT) and ultrasound (US). These factors may
cause difficulties in the accurate preoperative diag-
nosis of RCC in patients with chronic renal fail-
ure. We present a case of RCC associated with
ESRD and demonstrate the usefulness of spectral
Doppler US in its detection and differential diagnosis.
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CASE REPORT
A 27-year-old female with focal segmental glomer-
ulonephritis was referred for evaluation of ESRD
that had been followed for 2 years using US. The pa-
tient was undergoing continuous ambulatory perito-
neal dialysis and had no specific symptoms such as
gross hematuria, flank pain, or fever.
US showed diffuse parenchymal atrophy and
increased cortical echogenicity with multiple cysts
in both kidneys suggestive of ESRD with ACKD.
A small exophytic mass was noted at the lower pole
of the right kidney (Fig. 1). Color Doppler US showed
slight hypervascularity in the lesion. The Doppler
spectrum in the lesion showed a low-resistance
pattern with a resistive index of 0.56 (Fig. 2A),
while that in the renal parenchyma showed a high-
resistance pattern with a resistive index of 0.86
(Fig. 2B). The lesion was considered to be a true
tumor, most likely RCC, rather than a pseu-
dotumor caused by focal compensatory hypertrophy.
Right nephrectomy was performed, and pathology
revealed papillary RCC.
DISCUSSION
The prevalence of RCC is higher in patients with
ESRD on dialysis and after renal transplantation [1,
2]. US identifies RCC in the native kidneys of 3.8%
and 3.9% of ESRD patients pre- and post-transplan-
tation, respectively [1,2], which represents a 100-fold
increase compared with the general population.
Dunnill et al first described the association of ACKD
and RCC in patients on hemodialysis [3]. In their
autopsy study of 30 patients, 46% had ACKD and
20% had a renal tumor. Miller et al subsequently
reported a larger autopsy series of 155 hemodialysis
patients, in which ACKD was noted in 58%, renal
adenoma in 16%, and RCC in 2% of patients [4].
Further studies have shed light on the prevalence,
natural history, and risk factors for, both ACKD and
RCC in ESRD patients, both before and after renal
transplantation [1,2,5,6].
Since the article reported by Dunnill et al [3],
many radiographic imaging surveys of ESRD and
its complications have been reported [7,8]. Various
authors have suggested US alone [9], US and CT
Fig. 1. Longitudinal ultrasound of the right kidney shows
diffuse renal parenchymal atrophy and increased cortical
echogenicity. There is an exophytic mass (arrow) at the
lower pole.
Fig. 2. Spectral Doppler ultrasound images of the right
kidney. (A) Doppler spectrum in the mass (white arrows)
shows low-resistance arterial flow with a resistive index
of 0.56. (B) Doppler spectrum obtained in the adjacent
renal parenchyma shows high-resistance arterial flow
with a resistive index of 0.86. Black arrow = location
of sample volume.
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[8,10], or CT alone [7] as the appropriate technique
for monitoring these patients. The fibrotic, shrunken
kidneys seen in patients with ESRD are difficult to
image with US and compensatory focal hypertrophy
can be mistaken for a pseudotumor. The kidney
itself, as well as the fat and bowel that can fill in
the renal bed, adds to the difficulty in imaging.
Contrast-enhanced CT using a thin-section technique
produces better resolution of renal contours and
grading of ACKD changes in patients with ESRD
than US. CT enhancement helps define small cysts,
is useful in defining solid masses, and helps to dis-
tinguish focal hypertrophy from solid masses [11].
However, many patients with ESRD have abnormal
cardiovascular function and the bolus-enhanced
dynamic scanning technique carries the risk of fluid
overload. In addition, intravenous iodinated contrast
material may cause further deterioration in renal
function. Therefore, US is still routinely used to
evaluate both native and transplant renal dysfunction.
The results of US, however, often do not affect
the differential diagnosis or management of renal
disease. Indeed, despite marked improvements in
technology, gray-scale renal US has changed little
since the 1970s [12]. A series of articles published
during the past decade indicates the potential of
Doppler US for improving sonographic assessment
of renal dysfunction. Changes in intrarenal arterial
waveforms are associated with urinary obstruction,
several types of intrinsic renal disorders, and renal
vascular disease [13–16]. In ESRD, Doppler US has
been used in renovascular hypertension and renal
compromise resulting from chronic ischemia. Doppler
waveform analysis demonstrating reduced diastolic
flow and increased resistance supports this concept
[17]. However, Doppler study of ESRD is difficult
due to hypovascularity of the renal parenchyma.
In our case, the Doppler spectrum of the RCC
showed a low-resistance pattern, which was quite
different from the high-resistance spectrum of the
rest of the kidney. There have been few studies
reporting the value of spectral Doppler analysis in
differentiation between benign and malignant renal
masses [18,19]. Basically, most malignant tumors in
the body show a Doppler spectrum of high peak
systolic velocity and low resistance [18,19]. High
peak systolic velocity in renal malignancies is prob-
ably due to intratumoral arteriovenous shunting
[18]. Many malignant tumors secrete an angiogenic
factor that induces malignant neovascularization, a
requirement for both growth and metastasis [20,21].
These abnormal blood vessels lack the normal
requisite of smooth muscle cells within their walls
and are, therefore, more compliant and distensible.
Hence, resistance to flow is decreased and diastolic
flow is increased, resulting in a low-resistance flow
pattern [19]. It has been shown that pseudotumors,
solid masses composed of normal renal tissue that
mimics malignancy on gray-scale imaging, do not
have increased peak systolic velocity. Hence, spectral
Doppler US can be used to evaluate kidneys with
ESRD, especially when RCC is suspected.
Differential diagnosis between renal adenoma and
RCC is another point at issue. Renal adenoma is
seen more frequently than RCC in patients with
ACKD. In the article by Denton et al [6], 260 nephrec-
tomy reports were reviewed and renal adenoma and
RCC were found in 14% (35/260) and 4.2% (12/
260), respectively; 73% of RCCs coexisted with papil-
lary renal adenoma. There was a trend for RCC
cases to share similar risk factors with renal adenoma.
These findings support the concept that renal adenoma
and RCC share a common pathophysiologic factor.
Indeed, histopathologic studies of ACKD have shown
cellular changes suggesting that many RCC may
develop from papillary cystic hyperplasia, in a manner
analogous to the adenoma-carcinoma sequence in
the colon [22]. Differentiation of RCC from renal ade-
noma is possible by identifying a Doppler spectrum
of high peak systolic velocity and low resistance.
Patients with ESRD are monitored for the de-
velopment of RCC using serial US at periodic
intervals. Careful observation of changes in the
Doppler spectrum may help to detect RCC and
differentiate it from pseudotumor and renal adenoma.
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